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1. Introduction 
The term atopic dermatitis (AD) was first proposed by Wise & Sulzberger (Wise, 1993), who 
defined the condition as “confusing types of localized and generalized lichenification, 
generalized neurodermatitis or a manifestation of atopy.” AD (or atopic eczema) is 
recognized as a very common disease that affects at least 15% of children and is strongly 
associated with cutaneous hyper-reactivity to environmental triggers (Geha, 2003, Leung 
and Bieber, 2003, Novak et al., 2003). AD is characterized by complex symptoms, including 
chronic relapsing, extreme pruritus and eczematous skin disease, all of which are frequently 
associated with IgE hyperresponsiveness to environmental allergens (Hanifin, 1980, Larsen 
et al., 1986, Schultz Larsen, 1993). The rapid increase in the prevalence of AD over the past 
three decades has resulted in an intense effort to elucidate the underlying pathogenesis and 
in the use of radical treatments for this disorder (Taylor et al., 1984, Larsen et al., 1986, Geha, 
2003). The causative factors for AD generally fall into two categories: environmental and 
genetic factors. House dust mites and air pollution are included in the environmental 
category, and their involvement in the disease has been strongly suggested by 
epidemiological studies (Hanifin, 1982). Alternatively, genetic factors, including several 
different candidate regions, have been suggested from linkage studies on atopic and non-
atopic phenotypes see Morar et al., (2006) and references therein). The fact that multiple 
linkage regions have been associated with the disease might be due to: 1) the disease is 
polygenic and many different genetic factors may be affected with the diseases, 2) the 
disease is clinically heterogeneous and different subphenotypes are influenced by different 
risk loci, which is not always followed by one-to-one correspondence, 3) different 
populations have a different genetic pool and may have different genetic factors for the 
disease, and consequently genetic studies are still not good enough to correspond to these 
situations. Additionally, there is a lack of appropriate animal models for human AD except 
for the flaky tail (Flgft) mouse. The Flgft mouse carries a loss-of-function (LOF) mutation in 
the gene encoding filaggrin (FLG), and this LOF mutation causes the barrier abnormality. 
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The barrier abnormality is recently discovered to be linked to the incidence of AD (Oyoshi et 
al., 2009, Vercelli, 2009, Moniaga et al., 2010, O'Regan and Irvine, 2010).  
2. Mouse models for human AD 
To date, at least four mouse models for human AD have been developed in Japan. Two of 
four models, NC (NC/Nga) and NOA, are controlled by multiple genes, whereas the 
other two, DS-Hm and KOR-adjm, are controlled by a single gene. No responsible genes 
have been isolated yet from the polygenic AD models, even though the genetic loci were 
identified a decade ago. In contrast, the responsible genes for the monogenic AD models 
have been identified. Interestingly, the functions of the respective genes are completely 
different; one is a thermosensor in keratinocytes, whereas the other is an adapter protein 
in the NF-B signaling pathway. 
2.1 Polygenic mouse models for human AD: NC and NOA 
Two promising mouse models for human AD are the inbred strains named Nishiki Nezumi 
Cinnamon (NC) (Matsuda et al., 1997) and Naruto Research Institute Otsuka Atrichia 
(NOA) (Natori et al., 1999). The NC strain was originally established in 1957 by Prof. K. 
Kondo of Nagoya University from a stock derived from Japanese fancy mice, called Nishiki 
Nezumi (Kondo et al., 1969, Kondo, 1983, Festing, 1996). The NC mice spontaneously 
develop severe dermatitis in the presence of nonspecific allergens. Morbid NC mice exhibit 
AD symptoms, including itching, erythema, hemorrhage, edema, crust, drying, and 
excoriation/erosion hyperplasia of the epidermis region of the face, neck, and/or back, and 
the symptoms are exacerbated by aging (Matsuda et al., 1997). Furthermore, NC mice 
display some of the characteristic histopathological features of AD, such as macrophage and 
eosinophil invasion into the dermis, increased numbers and activation of mast cells and 
lymphocytes, a reduction in ceramide (Aioi et al., 2001), the appearance of activated mast 
cells, and CD4+ T cells in the lesion. These lines of evidence suggest that the symptoms 
shown by NC mice are quite similar to those of human AD from the clinical, pathological, 
and immunological perspective.  
As an alternative to the NC model, the NOA strain was derived from a male spontaneous 
mutant with sparse coat hair, which was obtained in 1982 by cross breeding between a 
female C3H/He mouse and a male ddY mouse at the animal facility of Naruto Research 
Institute, Otsuka Pharmaceutical Factory, Inc. and was then established as an inbred strain. 
The visible characteristic phenotype of the NOA mouse is that the mouse becomes 
completely hairless and smooth-skinned in adulthood until the development of skin lesions. 
In particular, ulcerative skin lesions are observed with a prevalence of 30% by the 10th week 
of age and 90% by the 20th week of age. In severe cases, the lesions extend to cover almost 
20% of surface area of the body. In addition, serological examination showed increased IgE 
levels, with significantly higher levels in the mice with ulcerative skin lesions, suggesting 
that IgE is also involved in the development of the lesions (Kondo et al., 1997). The 
susceptibility of NOA mice to AD is increased by S. aureus colonization of the skin, 
suggesting that the NOA model is a potentially useful animal model for evaluating the 
effects of antiseptic treatments on the disease (Kondo et al., 2006). NOA mice have also been 
subjected to therapy by Chinese herbal medicine (Lee et al., 2006) to survey factors 
associated with AD (Watanabe et al., 1999).  
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2.2 Details of the NC model 
Of the two models, the NC model has been more widely used to compare the phenotype 
between human AD patients and the mice, to explore causative genes (Ito et al., 2004, Ogawa 
et al., 2005, Fallon et al., 2009, Jung et al., 2011) and genetic loci (Kohara et al., 2001), and for 
drug development (Yamamoto et al., 2007, Shah et al., 2010, Tanaka and Matsuda, 2011) and 
the therapy of human AD (Takeda and Gelfand, 2009). Therefore, the immunological, 
pathological and genetic characteristics have been extensively examined in detail.  
To perform preclinical trials or to survey potential drug targets for AD using mice, a high 
incidence of AD onset is required. Thus, there is a drawback to using NC mice, namely, that 
the NC mice exhibit a very low rate of the spontaneous onset of AD under specific 
pathogen-free (SPF) conditions. Even under conventional (non-SPF) conditions, the 
incidence rates of AD are variable and depend on the circumstances of the animal facility in 
which the NC mice have been bred (Kikkawa et al., unpublished results). Therefore, 
experimental conditions for the onset of AD are necessary for a high and stable incidence of 
AD. Although hypersensitivity to some environmental factors is suggested to cause 
dermatitis, the precise factor remains unclear. The breakthrough identification of conditions 
to induce AD in NC mice was made by Morita and colleagues, who discovered that fur 
mites induced dermatitis associated with IgE hyperproduction in a substrain of mice, 
NC/Kuj (Morita et al., 1999), and the mite antigen-induced dermatitis was subsequently 
confirmed (Sasakawa et al., 2001). These lines of evidence suggested a new model system for 
antigen-induced dermatitis. Alternatively, dermatitis can also be induced in NC mice by a 
hapten, such as 2,4-dinitrofluorobenzene (DNFB) (Tomimori et al., 2002, Tomimori et al., 
2005), trinitrochlorobenzene (TNCB) (Taniguchi et al., 2003), or FITC (Hvid et al., 2009). 
Using these induced dermatitis models in NC mice, extensive surveys for therapeutic 
agents, both chemicals and herbal medicine, have been performed(Kobayashi et al., 2003, 
Lee et al., 2007, Jiang et al., 2009, Joo et al., 2009, Lee et al., 2010, Choi et al., 2011, Kim et al., 
2011, Park et al., 2011, Sung et al., 2011a, Sung et al., 2011b, Wu et al., 2011). 
2.3 Establishment of hairless NC mice for the development of drugs and 
comprehensive therapy for human AD  
Although the NC model is a promising mouse model for AD, it has another serious 
drawback, namely the existence of dense hair on the body. The dense hair disturbs the 
pathological observation of the symptoms in the earlier stages of AD onset and without hair 
shaving also interferes with the painting of an ointment to test its efficacy. Hair shaving 
itself leads to another severe problem, laboratory animal allergy (LAA). LAA is a form of 
occupational allergic disease. The development of LAA is due to the presence of IgE 
antibodies directed against animal proteins, and incidence rates are rapidly increasing. Hair 
shaving increases the chance of direct exposure of the researcher to the animal proteins, and 
the worst possible outcome of LAA is death by anaphylactic shock (Pacheco et al., 2003, 
Schweitzer et al., 2003, Matsui et al., 2004, Curtin-Brosnan et al., 2010). Therefore, a hairless 
model on an AD-prone genetic background would be an ideal and powerful tool for basic 
research, such as the discovery of the genes responsible for AD, and for drug development, 
such as the development of new ointment for the treatment of AD. 
We have generated a hairless mouse model for AD on the NC genetic background to study 
the pathophysiology of the disease and to screen ointment compounds as novel therapies 
for skin lesions. To generate the hairless mice, we applied a novel method that we recently 
developed for the ablation of specific cell lineages using diphtheria toxin (DT), also known 
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as the TRECK (Toxin receptor mediated cell knockout) method (Saito et al, 2001). To achieve 
the specific ablation of hair shafts, we used the promoter of the keratin 71 (Krt71/formerly 
krt2-6g or mK6irs1) gene, which encodes a type 2 keratin filament protein. The Krt71 gene 
is involved in hair development, and mutation of the gene affects the morphology of the 
coat hair because the gene product is expressed in the cells of the inner root sheath (IRS). 
Several allelic mutations found in the Caracul (Ca) phenotype are morphologically very 
similar to the classic wavy coat mutation in laboratory mice (Kikkawa et al., 2003). 
Therefore, we constructed a minigene in which the expression of the human DT receptor, 
the intrinsic mechanism of which is to bind the heparin-binding EGF (Naglich et al., 1992a, 
Naglich et al., 1992b), is driven by the promoter of the Krt71 gene (Fig. 1A). The minigene 
was introduced directly into pronucleus-stage eggs of the NC strain to generate ‘NC/Nga-
Krt71-TRECK’-transgenic (Tg) mice. Unexpectedly, NCN24, one of the two NC Tg founder 
lines, exhibited a dominant hairless phenotype without the administration of DT (Fig. 1B). 
Furthermore, a predisposition to atopic dermatitis-like symptoms and the elevation of IgE 
levels were observed in both the NCN24 and the wild type NC strain (Fig. 2). Our newly 
developed NCN24 mice will be useful to assess drugs for AD therapy because they allow 
the monitoring of skin inflammation without shaving (Takada et al., 2008b). DT is highly 
 
 
(a) 
 
 
(b) 
(a) Approximately 9 kb of the Krt71 promoter region was amplified by PCR using genomic C57BL/6J 
mouse DNA. The Krt71 promoter was cloned into the BamHI and NotI sites of the TRECK vector (Saito 
et al. 2001). The 11-kb NotI/XhoI fragment containing the Krt71 promoter, the -globin intron, and 
human HB-EGF cDNA was excised, purified and used for microinjection. 
(b) NC/Nga-Tg(Krt71-HBEGF)24Rin (NCN24) mice at postnatal day 14 (P14) exhibit a hairless 
phenotype over the whole body without DT treatment compared with the wild type littermates. 
Fig. 1. Generation of Krt71 promoter/human HB-EGF transgenic NC mice 
Human 
HB-EGF cDNA 
-Globin
intron Krt71 Promoter/Enhanser 
-Globin/SV40 
polyA signals 
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toxic to humans, and therefore, it is not an appropriate agent to use in experimental models 
intended to investigate the pathogenic aspects relevant to human disease. DT treatment and 
the attention required for DT administration in mice would no longer be needed if the novel 
hairless Tg mice were used. 
The NCN24 strain is co-isogenic to the wild type NC strain because the minigene was directly 
introduced into the NC genome by microinjection as described earlier. This means that, with 
the exception of coat hair, no phenotypic differences are expected between NCN24 mice and 
the original NC mice. We confirmed this by comparing the coat hair, the time to AD onset, the 
progression of AD, the serum IgE level and its change over time, and the composition of the 
immune cell populations in the bone marrow, spleen and thymus (Table 1) between NCN24 
mice and the original NC mice (Takada et al., 2008b). As expected, there were no differences 
between the two strains except for coat hair. Therefore, we conclude that NCN24 mice will be 
useful for assessing the efficacy of drugs and for developing AD therapy because the model 
enables researchers to monitor skin inflammation without shaving.  
A remaining issue is why the hairless phenotype occurred in the NCN24 line without the 
administration of DT because the TRECK method upon which the model was designed is 
based on the aberration of a cell lineage by DT through the human DT receptor (DTR) 
driven by a tissue-specific promoter introduced into the transgenic minigene (Saito et al, 
2001). The key evidence for this phenomenon, namely, hairless phenotype without DT 
administration is that the original cellular function of DTR is heparin-binding EGF, an 
important role of which is the molecular regulation of the hair cell cycle (Mak and Chan, 
2003). From the P1 to P12 stages in the NCN24 mice, we only observed immature or 
irregular hair follicles distributed in the skin sections, indicating that the proper processes  
 
 
Fig. 2. The severity and histological features of the atopic dermatitis-like skin lesions in wild 
type (upper row) and NCN24 (lower row) mice during the progression of AD. The atopic 
dermatitis-like skin lesions were observed in the pinnae and scapula of the dorsal area along 
with congestion and scaly symptoms, and advanced dermatitis was seen in the middle- and 
right-side photographs in both wild type NC/Nga (upper low) and NCN24 mice (lower low). 
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Table 1. The number of immune cells in wild-type (wt) and NCN24 mice. 
were not occurring in the first hair cycles, with congestion and scaly symptoms, and 
advanced dermatitis was seen in both wild type and NCN24. starting from the early anagen 
phase. The mechanisms that potentially cause the hairless phenotype could be simple; 
specifically, it could be the ectopic expression of the DTR (HB-EGF) driven by the Krt71 
promoter in the inner root sheath (IRS). As described earlier, HB-EGF is the major molecular 
regulator for the hair cell cycle (Mak and Chan, 2003). Transgenic mice in which HB-EGF 
was overexpressed by a ubiquitous expression vector showed hair abnormalities, including 
a bare-patch phenotype. This phenotype was attributed to the ectopic and irregular 
overexpression of HB-EGF in the IRS of the Tg mice (Takada et al., 2008b). Similarly, a 
spontaneous mutation at the Krt71 locus also caused a bare-patch phenotype (Poirier et al., 
2002). Therefore, the most likely mechanism causing the hairless phenotype in our Tg mice 
is the ectopic overexpression of HB-EGF, which disturbs the initiation of the normal hair cell 
cycle. Specifically, the Krt71 promoter in the transgene guaranteed the IRS-specific 
expression of HB-EGF, which augmented the ectopic expression of HB-EGF in the IRS. 
Several mechanisms have previously been reported in which molecular signaling via the 
ErbB family, the members of which are involved downstream of HB-EGF signaling, is 
critical for skin and hair development during the neonatal period. HB-EGF is an essential 
molecule for the initiation of hair growth and for entry into the appropriate phase of the hair 
cycle (Mak & Chan 2003), although it is not clear how the human HB-EGF transcript might 
affect the development of the hair follicles in the neonatal period of NCN24 mice. 
Evidence of an alternative explanation is that the phenotype we described partially 
resembles several phenotypic features that were reported in studies of the hairless mouse 
harboring a hr/hr mutation (Brooke, 1926). The hairless (hr) mutant mice have been well 
characterized and exhibit a hairless phenotype due to a failure of the follicular papilla to 
Imune cells 
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ascend to the permanent portion of the hair follicle during the first catagen phase 
(Panteleyev et al., 1999). Therefore, we considered that a functional defect in the follicular 
papilla early in the anagen phase of NCN24 mice could cause an irregular sorting of the 
melanin granules and the weak and degraded features of the hair shaft. Unlike in the hr 
phenotype mice, hair degradation was observed in the newborn animals of the NCN24 line, 
demonstrating that in these hairless mice, the development of the hair follicles progressed 
normally, while the first cycle of the anagen phase was impaired (Takada et al., 2008b). 
A third possibility is that the insertion disrupted a gene (s) that is indispensable for hair 
development. However, this is very unlikely because fluorescence in situ hybridization (FISH) 
analysis revealed that the transgene was detected in the telomeric region of chromosome 14, 
where no indispensable genes have been reported thus far (Takada et al., 2008b). 
2.4 Attempts to identify the genes responsible for AD using polygenic AD models 
Linkage analyses and a quantitative traits loci (QTL) analysis have been performed for the 
two models for human AD, NC and NOA, to identify the genetic loci responsible for AD. 
Using intercrossing or backcrossing between an AD model and a non-AD counterpart, the 
segregation ratio of F2 or N2 progeny was examined, and it was discovered that the 
segregation ratios did not follow Mendelian inheritance, suggesting that the AD phenotype 
is controlled by multiple genes. In fact, several loci were identified in both NC and NOA, as 
discussed below (Natori et al., 1999, Kohara et al., 2001, Watanabe et al., 2001). Despite 
extensive attempts spanning a decade, no responsible genes have yet been identified by 
positional cloning. 
2.4.1 Linkage analyses for AD in NOA 
Detailed linkage analyses revealed a significant co-segregation between ulcerative skin 
lesions and markers on murine chromosome 14. A statistical analysis indicated that the 
critical region was in the vicinity of D14Mit236 and D14Mit160 (Natori et al., 1999). These 
analyses also identified two additional modifier genes: one in the middle of chromosome 7 
and the other in the telomeric region of chromosome 13 (Watanabe et al., 2001). 
2.4.2 Linkage analyses for AD in NC 
We performed a linkage disequilibrium analysis between AD or hyper-IgE-emia and 
chromosome-specific microsatellite loci in the backcrossed progeny of NC and MSM/Ms 
(MSM) mice. The MSM line originated from Japanese wild mice, Mus musculus molossinus 
(Moriwaki et al., 2009), and maintains a very large amount of genetic diversity in the 
genome (Kikkawa et al., 2001, Sakai et al., 2005, Takada et al., 2008a) compared with other 
classical inbred strains, such as BALB/c and C57BL/6, and we often use the MSM strain to 
perform finer genetic mapping. This analysis led to two important observations: 1) the 
occurrence of dermatitis is not associated with an elevated serum IgE level (Kohara et al. 
unpublished); and 2) the major locus responsible for dermatitis (the derm1 locus) is located 
on the middle of chromosome 9 (Fig. 3). We also discovered additive (potentially modifier) 
loci with suggestive level on a few chromosomes (Kikkawa et al., unpublished). This genetic 
status resembles that of human AD because human AD is also polygenic, and mono- or 
oligogenic AD has not yet been reported. Furthermore, the association between hyper-IgE-
emia and dermatitis/eczema is not always observed in humans. Unfortunately, we have not 
found any significant or suggestive loci for hyper-IgE-emia. 
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2.5 Monogenic mouse models for human AD: DS-Nh and KOR-adjm 
In contrast to the polygenic AD models, there are two models in Japan that are the result of 
a single mutation. One is DS-Nh, and the other is KOR-adjm. Unlike the mouse models with 
polygenic factors, the genes responsible for dermatitis, DS-Nh and KOR-adjm, have been 
identified from the monogenic AD models. 
2.5.1 The DS-Nh gene is the transient receptor potential cation channel, subfamily V 
member 3 (TRPV3) 
A spontaneous mutant strain with a hairless phenotype (DS-Nh) was isolated from an 
inbred strain, DS, which was developed in 1954 from an outbred dd stock of the Central 
Institute for Experimental Animals, Tokyo, Japan. The DS-Nh mice exhibit ulcerative skin 
lesions on the cheek, neck and shoulder as initial symptoms when the mice are transferred 
from SPF to conventional conditions. The skin lesions have been associated with hyper-IgE-
emia triggered by Staphylococcus aureus infection (Watanabe et al., 2003a, Watanabe et al., 
2003b). The DS-Nh mice also exhibit heavy scratching behavior to itching, which is 
associated with elevated levels of histamine and nerve growth factor in the serum and/or 
skin tissues (Yoshioka et al., 2006). Furthermore, the DS-Nh mice exhibit other features that 
resemble human AD, such as significantly increased serum levels of IL-4 and IL-13 (Hikita 
et al., 2002) and increased numbers of whole mast cells and CD4+ T cells (Yoshioka et al., 
2006). Therefore, the DS-Nh mouse is a model of the pruritus associated with human AD.  
 
 
Fig. 3. Using (NC x MSM) N2 mice, a linkage disequilibrium analysis was performed, and a 
single significant genetic locus responsible for AD was identified on chromosome 9. We 
designated the locus derm1. 
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The Nh mutation is controlled by a single dominant mutation that occurred in the transient 
receptor potential (TRP) cation channel, subfamily V member 3 (Trpv3). The TRP channels 
are expressed ubiquitously in the body and are thought to have important roles in 
maintaining proper vital status (Okuhara et al., 2007) because they are critical mediators in 
sensory systems and respond to temperature, touch, pain and other important stimuli. TRP 
channels are divided into six main subfamilies, including TRPV (Clapham, 2003). The TRPV 
subfamily is expressed in the skin, keratinocytes and hair follicles and is activated by 
temperatures higher than 32-39C (Peier et al., 2002). The Gly573Ser substitution of Trpv3 
leads to increased ion-channel activity in keratinocytes, which influences the hair growth 
cycle in mice (Imura et al., 2007). By studying dermatitis in DS-Nh mice, two major 
pathways have been identified; one is the interaction between the gain-of-function Trpv3 
mutation and NKT cells with the T-cell receptor Vand the other is the synergistic 
production of interleukin-13 (IL-13) through the activation of Toll-like receptor 2 by 
staphylococcal enterotoxin C-producing S. aurous (Yoshioka et al., 2007, Imura et al., 2008, 
Imura et al., 2009, Yoshioka et al., 2009). 
2.5.2 The KOR-adjm gene is TNFR-associated factor 3-interacting protein 2 
(TRAF3IP2) 
Recently, we identified a new mouse model for human atopic dermatitis, the phenotype of 
which is controlled by a single recessive mutation. The spontaneous mutant mice, which 
exhibited high levels of serum IgE and an atopic dermatitis (AD)-like skin disease, were 
identified from a colony of the KOR inbred strain, which was derived from Japanese wild 
mice (Figs. 4, 5). No segregation was observed between hyper-IgE–emia and dermatitis in 
BALB/c x KOR mutant N2 mice. Furthermore, linkage analysis showed that both 
phenotypes are controlled by a same single recessive locus, and thus we designated the   
 
 
 
 
(a) 
(a) Phenotype segregation in the KOR colony. A pedigree of the KOR strain in which adjm mutant mice 
were first discovered (shown by arrows). The squares and circles represent males and females, 
respectively. The closed and open symbols represent affected and non-affected individuals, 
respectively. 
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(b) 
(b) The appearance of a healthy (left) KOR-adjm/adjm mouse after 
KOR-adjm/+ mouse disease onset is shown (right). 
Fig. 4. adjm mutation identified from the KOR mouse colony. 
 
 
Fig. 5. Age-dependent increase in serum IgE level. The increase began at 5 weeks of age, and 
the IgE level reached 13,104 ng/ml by the age of 11 weeks. The IgE levels in female mutant 
(KOR-adjm/adjm) mice were twice as high as those in male mice 
locus as adjm (atopic dermatitis from Japanese mice). We isolated the gene responsible for 
the AD-like phenotypes by positional cloning and discovered that the gene is the mouse 
homologue of the human TNFR-associated factor 3-interacting protein 2 (TRAF3IP2), which 
has formerly been called ACT1 (Li et al., 2000) or CIKS (Leonardi et al., 2000) protein. 
Furthermore, the gene included a single point mutation leading to the substitution of a stop 
codon for glutamine at amino acid position 214 (Fig. 6) (Matsushima et al., 2010). TRAF3IP2 
was first reported as an adopter protein that is associated with and activates IB kinase and 
stimulates both the NF-B and the JNK signaling pathways (Li, 2008). It has been shown to 
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function as an adaptor protein in signaling pathways mediated by the TNFR superfamily 
members CD40 and B cell-activating factor in epithelial cells and B cells as well as in the IL-
17 -mediated signaling pathway (Li et al., 2000). Our results suggest that dysfunction of the 
TRAF3IP2 protein causes hyper-IgE-emia through the CD40- and B cell-activating factor-
mediated pathway in B cells and causes skin inflammation through the IL-17–mediated 
pathway. This study demonstrates that the TRAF3IP2 protein has an important role in AD 
and suggests that the protein could be a therapeutic target for the treatment of AD (see 
Matsushima et al. (2010) and references therein). 
 
 
(a) 
(a) Comparison of the mouse and human TRAF3IP2 protein sequences. The amino acid sequences in 
open boxes or underlined with broken or solid lines are the TRAF binding sites, the helix-loop-helix 
domain, and the coiled-coil domain, respectively. 
 
 
(b) 
(b) The domain structure of the TRAF3IP2 protein. The adjm mutation causes the truncation of the 
TRAF3IP2 protein at amino acid 214. The truncated form lacks a C-terminal TRAF-binding site and a C-
terminal coiled-coil domain. 
Fig. 6. Alignment of amino acid sequence between mouse and human of TRAF3IP2 protein 
and the predicted structure of TRAF3IP2 protein in wild-type and adjm mutant 
3. Conclusion 
Four promising mouse models for human AD have been established thus far in Japan. Two 
models are polygenic, and the pathology and the onset of the disease are very similar to 
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human AD, although no responsible genes have been isolated. In contrast, the other two 
models are monogenic, and the responsible genes have been identified. One, DS-Nh, is a 
gain-of-function mutation in the Trpv3 locus, whereas the other, KOR-adjm, is a loss-of-
function mutation in the Traf3ip2 locus. The former mutation demonstrated the strong 
involvement of IL-13 in association with the Trpv3 locus and the TCRVb (NKT cell) 
haplotype. The latter mutation demonstrated the involvement of CD40L/BAFF signaling for 
B cell activation and of the IL-17 signaling pathway for the autoimmune and inflammatory 
responses through the activation of NF-B. The involvement of the NF-B pathway to AD is 
commonly suggested in both human and mouse, and therefore the finding shown here will 
facilitate the development of therapies and drugs. 
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Atopic Dermatitis is a common disease characterized by inflamed, itching and dry skin. This relapsing allergic
disorder has complex etiology and shows a remarkably high clinical heterogeneity which complicates the
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An overview of the clinical diagnostic criteria and the disease management protocols commonly used is given
in the third section (Diagnosis and Clinical Management). The last section (New Treatments) describes new
therapeutic approaches that are not widely used but are currently being studied due to preliminary evidence
showing a clinical benefit for Atopic Dermatitis.
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